|
|
|
|
Biotechnology & Pharmaceuticals Industry
Cash-Flow Margins, Effective Tax Rates Information & Trends
Effective Tax Rate
Statistics |
| |
| Effective Tax Rate Comment |
Biotechnology & Pharmaceuticals Industry's effective tax rate in 4 Q increased compare to previous quarter to 51.51 %, above Industry average.
Within Healthcare sector 4 other industries had lower effective tax rate. Effective tax rate total ranking has deteriorated compare to previous quarter from to 68.
|
| Effective Tax Rate Statistics |
| High |
Average |
Low |
| 293.47 % |
11.13 % |
-769.54 % |
| 2. quarter 2023 |
|
3. quarter 2023 |
| Effective Tax Rate Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 5 |
| Overall |
# 68
|
Effective Tax Rate
Statistics |
|
|
| Effective Tax Rate Comment |
Biotechnology & Pharmaceuticals Industry's effective tax rate in 4 Q increased compare to previous quarter to 51.51 %, above Industry average.
Within Healthcare sector 4 other industries had lower effective tax rate. Effective tax rate total ranking has deteriorated compare to previous quarter from to 68.
|
| Effective Tax Rate Statistics |
| High |
Average |
Low |
| 293.47 % |
11.13 % |
-769.54 % |
| 2. quarter 2023 |
|
3. quarter 2023 |
|
| Effective Tax Rate Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 5 |
| Overall |
# 68
|
|
Industry: Biotechnology & Pharmaceuticals ▼
|
Category:
|
|
| Biotechnology & Pharmaceuticals Industry |
4 Q |
3 Q |
2 Q |
1 Q |
4 Q |
|
|
2024 |
2024 |
2024 |
2024 |
2023 |
| Free Cash Flow Margin |
37.23 % |
27.01 % |
11.31 % |
5.64 % |
5.04 % |
| Free Cash Flow Margin (TTM) |
25.26 % |
18 % |
13.9 % |
16.33 % |
14.41 % |
| Free Cash Flow Margin Ranking |
# 72 |
# 5 |
# 87 |
# 9 |
# 69 |
| Net Cash Flow Margin |
34.63 % |
2.03 % |
- |
- |
- |
| Net Cash Flow Margin (TTM) |
4.34 % |
- |
- |
- |
- |
| Net
Cash Flow Margin Ranking |
# 72 |
# 5 |
# 87 |
# 9 |
# 69 |
| Effective Tax Rate |
51.51 % |
5.04 % |
66.13 % |
- |
25.2 % |
| Effective Tax Rate (TTM) |
- |
- |
- |
- |
64.3 % |
| Effective Tax Rate Ranking |
# 68 |
# 83 |
# 80 |
# 44 |
# 61 |
Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.
Free Cash Flow Margin Comment |
Despite sequential Revenue deterioration in 4 Q of -0.05 % Biotechnology & Pharmaceuticals Industry increased Free Cash Flow by 48.5 %. Free Cash Flow Margin grew to 37.23 % above Industry average Free Cash Flow Margin.
On the trailing twelve months basis Free Cash Flow Margin in 4 Q grew to 25.26 %.
Within Healthcare sector 4 other industries have achieved higher Free Cash Flow Margin. Free Cash Flow Margin total ranking has deteriorated compare to previous quarter from to 72.
|
| Free Cash Flow Margin Statistics |
| High |
Average |
Low |
| 49.5 % |
27.61 % |
-24.15 % |
| 4. quarter 2019 |
|
4. quarter 2024 |
| Free Cash Flow Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 5 |
| Overall |
# 72
|
Net Cash Flow Margin Statistics |
|
|
| Net
Cash Flow Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 2 |
| Overall |
# 56
|
| Net Cash Flow Margin Statistics |
| High |
Average |
Low |
| 109.85 % |
0.67 % |
-134.64 % |
| 4. quarter 2019 |
|
2. quarter 2020 |
| Net
Cash Flow Margin Comment |
Despite sequential Revenue deterioration in 4 Q of -0.05 % Biotechnology & Pharmaceuticals Industry increased Net Cash Flow by 1599.36 %. Net Cash Flow Margin grew to 34.63 % above Industry average Net Cash Flow Margin.
On the trailing twelve months basis Net Cash Flow Margin in 4 Q grew to 4.34 %.
Within Healthcare sector only one Industry has achieved higher Net Cash Flow Margin. Net Cash Flow Margin total ranking has deteriorated compare to previous quarter from to 56.
|
Net Cash Flow Margin Statistics |
|
|
| Net
Cash Flow Margin Industry Ranking |
| Within: |
No. |
| Healthcare Sector |
# 2 |
| Overall |
# 56
|
|
| Net Cash Flow Margin Statistics |
| High |
Average |
Low |
| 109.85 % |
0.67 % |
-134.64 % |
| 4. quarter 2019 |
|
2. quarter 2020 |
| Net
Cash Flow Margin Comment |
Despite sequential Revenue deterioration in 4 Q of -0.05 % Biotechnology & Pharmaceuticals Industry increased Net Cash Flow by 1599.36 %. Net Cash Flow Margin grew to 34.63 % above Industry average Net Cash Flow Margin.
On the trailing twelve months basis Net Cash Flow Margin in 4 Q grew to 4.34 %.
Within Healthcare sector only one Industry has achieved higher Net Cash Flow Margin. Net Cash Flow Margin total ranking has deteriorated compare to previous quarter from to 56.
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
